Current Activities

  • Real-world Access to T cell-directed Therapies in Multiple Myeloma: Driving Away Health Disparities | Tweetorial #2

    Despite advances in the treatment for multiple myeloma (MM), significant disparities exist for African American patients diagnosed with Multiple Myeloma.

    This Twitter-based Tweetorial will explore disparities and potential strategies to inequities in the management of patients with MM.

  • Best Practice for Providing T-cell Therapies in Multiple Myeloma | Tweetorial #3

    This X-based Tweetorial seeks to provide HCPs with best practices in the provision of T-cell therapies for patients with RRMM.

  • Acute Toxicities w/ BCMA-directed Therapies in Multiple Myeloma | Tweetorial #4

    Understanding the underlying mechanisms of toxicity of BCMA-directed therapies in patients with MM is critical to appropriate use of these therapies.

    This Twitter-based Tweetorial will explore the safety of BCMA-directed therapies for MM, as well as best practices to manage acute toxicities associated with these agents.

  • Delayed Toxicities w/ BCMA-directed Therapies in Multiple Myeloma | Tweetorial #5

    Understanding the underlying mechanisms of toxicity of BCMA-directed therapies in patients with MM is critical to appropriate use of these therapies.

    This Twitter-based Tweetorial will explore the safety of BCMA-directed therapies for MM, as well as best practices to manage delayed toxicities associated with these agents.

  • COVID Outpatient: Smarter in Minutes #3 ~ Paxlovid

    The goal of this proposed educational initiative is to improve the familiarity of health care practitioners (HCPs) with the evidence supporting the use of antivirals in the outpatient setting. This short, Smarter in Minutes episode focuses key considerations for Paxlovid in the treatment of COVID-19.

  • COVID Outpatient: Smarter in Minutes #4 ~ Remdesivir

    The goal of this proposed educational initiative is to improve the familiarity of health care practitioners (HCPs) with the evidence supporting the use of antivirals in the outpatient setting. This short, Smarter in Minutes episode focuses key considerations for remdesivir in the treatment of COVID-19.

  • COVID Outpatient: Smarter in Minutes #5 ~ Molnupiravir

    The goal of this proposed educational initiative is to improve the familiarity of health care practitioners (HCPs) with the evidence supporting the use of antivirals in the outpatient setting. This short, Smarter in Minutes episode focuses key considerations for molnupiravir in the treatment of COVID-19.

  • Expert Consult: Selecting BCMA- and GPRC5D-directed Therapies

    This video-based Expert Consult will explore the efficacy and safety data as well as clinical utility of approved BCMA- and GPRC5D-directed bispecific antibodies and BCMA-directed CAR-T call therapies for the treatment of RRMM.

  • COVID Outpatient: Smarter in Minutes #6 ~ Long COVID

    This short, Smarter in Minutes episode focuses key considerations for diagnosis, management, and research initiatives for Long COVID.

  • Short Bowel Syndrome Patient Case Game

    Short bowel syndrome (SBS) is a complex clinical condition that occurs from reduced or loss of intestinal absorption. With multiple treatment modalities available, combined with the unique challenges associated with this condition, it is becoming increasingly understood that patients with SBS are best managed under a model of coordinated care.

    This CME-certified, patient case game will allow learners to navigate the care of a fictional patient with SBS. As clinical decisions are made, feedback will be given to guide you in providing optimal care.

  • How I Practice: mUC Treatment Landscape

    With the expansion of the therapeutic armamentarium in metastatic urothelial carcinoma (mUC) the oncology care team is faced with interpreting a significant amount of new data, evolving guidelines, and nuanced considerations in clinic regarding practical application of these agents.

    This activity, a X/Twitter-based How I Practice video focuses on the treatment landscape in first-, second- and subsequent-lines of therapy in metastatic disease.

  • How I Practice: mUC Guidelines

    With the expansion of the therapeutic armamentarium in metastatic urothelial carcinoma (mUC) the oncology care team is faced with interpreting a significant amount of new data, evolving guidelines, and nuanced considerations in clinic regarding practical application of these agents.

    This activity, a X/Twitter-based How I Practice video focuses on NCCN, EAU, and ESMO guidelines in metastatic disease.

  • mUC Tweetorial: 1L & Maintenance Therapies

    This Tweetorial explores the efficacy and safety data behind first-line and maintenance treatments for patients with metastatic urothelial carcinoma.

  • COVID Outpatient: Smarter in Minutes ~ Disparities

    This short, Smarter in Minutes segment focuses on COVID-19 infections risks and outcomes for historically marginalized/socially vulnerable populations. Access to care and treatments will also be covered while providing practical actions HCPs can take to reduce disparities.

  • COVID Outpatient: Crack the Case ~ DDIs

    This short, video-based Crack the Case activity will test your ability to select the appropriate management strategy for patients with COVID taking concomitant medications in the outpatient setting.

  • MondayNightIBD Crohn's Series

    This series of 6 activities, hosted in partnership with MondayNightIBD, will focus on treat-to-target approaches, non-invasive imaging strategies, and histologic assessment in the management of Crohn’s disease. All activities can be found on the program landing page linked here.